After leading the NIH team that designed the Covid-19 vaccine, Kizzmekia S. Corbett will focus her new Harvard lab on non-Covid coronaviruses and other viral threats to fill in knowledge gaps that could facilitate the response to future outbreaks.
But first, omicron.
Corbett left the agency but is still volunteering with the Vaccine Research Center, which has one of a number of scientific teams focusing on the latest coronavirus variant to stir worldwide concern, while her lab space is renovated and she builds her team.
The emergence of omicron has pulled in Corbett and scientists worldwide as they seek to ...
Learn more about a Bloomberg Law subscription.
Read Full Story:
https://news.bloomberglaw.com/health-law-and-business/former-nih-covid-vaccin...